Conversely, NEFL (41), key protein involved in axonal integrity pathways, and RGN (42), a regulator of calcium signaling and mitochondrial homeostasis, become increasingly important in predicting clinical stages of AD, reflecting progressive neuronal cytoskeletal disruption and axonal degeneration. The gene discussed is RGN; the disease is Alzheimer disease.